• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,303.90 1,152.30(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,054.00 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novelix Pharmaceuticals Ltd Trading

  • Indian Private
  • BSE Code : 33252.0
  • ISIN : INE314I01036
68.00 4 (5.92%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    66.00

  • Today’s High

    70.00

  • Open

    67.00

  • Perv Close

    64.20

  • 52W Low

    49.01

  • 52W High

    92.00

Key Indicators

  • P/E(TTM)

    53.54

  • Mar.Cap (₹Cr.)

    193.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.08

  • Debt-Equity Ratio

    5.92

  • AGM Date

    04-Nov-2026

  • EPS

    1.27

  • P/E Ratio

    53.54

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    193.60

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.47

  • BV (₹)

    23.10

  • Sales( ₹ in Cr.)

    132.31

  • NP (in Cr.)

    2.56

  • NP Var(%)

    2926.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    193.60

  • 52 Week High

    92.00

  • 52 Week Low

    49.01

  • Price BSE

    68.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    193.60

  • P/C Ratio

    72.80

  • P/E Ratio

    75.70

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 132.31 30.72 4.22 1.92 1.14 1.31
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 132.31 30.72 4.22 1.92 1.14 1.31
Other Income 0.03 0.02 0.31 0.00 0.25 0.00
Stock Adjustments 13.59 -0.35 0.37 0.29 0.28 -0.14
Total Income 145.93 30.39 4.90 2.21 1.67 1.17
EXPENDITURE :            
Raw Materials 140.30 29.22 4.21 1.64 1.09 0.88
Power and Fuel Cost 0.07 0.03 0.01 0.01 0.01 0.01
Employee Cost 0.71 0.07 0.13 0.16 0.14 0.15
Other Manufacturing Expenses 0.15 0.02 0.01 0.02 0.02 0.03
Selling and Administration Expenses 1.12 0.56 0.35 0.36 0.38 0.31
Miscellaneous Expenses 0.01 0.32 0.14 0.01 1.53 2.98
Employee Benefit Expenses 0.71 0.07 0.13 0.16 0.14 0.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 142.35 30.22 4.84 2.21 3.17 4.36
Operating Profit 3.58 0.16 0.06 0.00 -1.49 -3.19
Interest 0.07 0.00 0.00 0.00 0.00 0.00
Gross Profit 3.51 0.16 0.06 0.00 -1.49 -3.19
Depreciation 0.10 0.04 0.04 0.06 0.07 0.08
Profit Before Tax 3.41 0.12 0.02 -0.06 -1.56 -3.27
Current Tax 0.83 0.03 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 0.01 0.01 0.00 -0.01 0.00
Reported Net Profit 2.56 0.08 0.01 -0.06 -1.56 -3.27
Extraordinary Items 0.00 0.00 0.00 0.00 -0.02 0.00
Adjusted Net Profit 2.56 0.08 0.01 -0.06 -1.54 -3.27
Adjustment below Net Profit 0.00 0.00 -0.01 0.01 0.00 0.00
P & L Balance brought forward -1.88 -1.96 -1.96 -2.37 -0.81 2.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.01 0.00 0.07
P & L Balance carried down 0.68 -1.88 -1.96 -2.43 -2.37 -0.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.21 0.08 0.01 -0.07 -1.93 -4.04
Earnings Per Share(Adj)-Unit Curr 1.21 0.08 0.01 -0.07 -1.93 -4.04
Book Value 22.05 17.63 9.08 8.88 8.94 10.87
Book Value(Adj)-Unit Curr 22.05 17.63 9.08 8.88 8.94 10.87

Shareholding Pattern

  • Promoter Group

    54.29%

  • Public Share Holding

    45.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,002,000 35.13 10,002,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,455,733 19.16 5,455,733 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,457,733 54.29 15,457,733 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 418,651 1.47 410,551 21
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 234,447 0.82 234,447 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 39,684 0.14 39,684 39
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,698,266 37.58 10,665,466 84
Individuals holding nominal share capital up to Rs. 1 lakh 1,481,172 5.20 1,198,462 3,025
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 125,500 0.44 125,500 1
Sub Total 13,012,267 45.71 12,688,657 3,184
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,470,000 100.00 28,146,390 3,192

Company Background

Novelix Pharmaceuticals LtdTrading

  • Novelix Pharmaceuticals Ltd
  • BSE Code : 33252.0
  • ISIN : INE314I01036

  • Incorporation Year

    1994

  • Registered Office

    4-4-231/1/2/ABC Inderbagh
    Sultan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-24757370

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Nishita Kalantri

  • Auditor

    CVS Bala Chandra Rao & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Novelix Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novelix Pharma. 68.00 132.34 132.31 53.54 10.56
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77